Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says

Federal regulators on Tuesday told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss medications. The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to su...

Redirecting to full article...